John Murphy, M.D., M.P.H., D.P.H. CEO COVID Long-haul Foundation
Abstract
Background
Long COVID, also termed Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), is a complex multisystem disorder characterized by persistent symptoms extending beyond the acute phase of infection. Among the most prevalent and disabling manifestations is dysautonomia, encompassing orthostatic intolerance, postural orthostatic tachycardia syndrome (POTS), neurocardiogenic syncope, gastrointestinal dysmotility, thermoregulatory abnormalities, sleep disruption, endocrine dysregulation, and neurocognitive dysfunction. Recent investigations increasingly implicate neuroimmune injury, microvascular pathology, viral persistence, autonomic neuropathy, and vagal dysfunction as central drivers of disease pathogenesis. Quantitative autonomic testing studies published during 2025–2026 continue to demonstrate measurable autonomic abnormalities in substantial subsets of Long COVID patients.
Objectives
To review current understanding of Long COVID-associated dysautonomia, emphasizing etiology, pathology, physiology, clinical assessment, vagal nerve involvement, endocrine consequences, multisystem manifestations, disease progression, and evolving therapeutic approaches.
Data Sources
Peer-reviewed literature, autonomic testing studies, systematic reviews, mechanistic investigations, and emerging clinical trials published through 2026.
Conclusions
Long COVID dysautonomia appears to arise from overlapping biological mechanisms including autonomic neuropathy, neuroinflammation, immune dysregulation, endothelial dysfunction, mitochondrial injury, microvascular abnormalities, and impaired vagal signaling. Although no universally effective treatment currently exists, expanding evidence supports individualized management incorporating autonomic rehabilitation, volume expansion, pharmacotherapy, neuromodulation, and targeted investigation of underlying immune and neurovascular abnormalities.
Introduction
Five years after the onset of the SARS-CoV-2 pandemic, Long COVID remains one of the most significant chronic disease burdens facing modern medicine. Characterized by persistent or newly emerging symptoms occurring after acute infection, Long COVID affects multiple organ systems and exhibits remarkable clinical heterogeneity. Neurologic, cardiovascular, respiratory, gastrointestinal, endocrine, and immunologic manifestations frequently coexist, suggesting disruption of fundamental regulatory pathways rather than isolated organ pathology.
Among these pathways, the autonomic nervous system has emerged as a particularly important target. Dysautonomia is increasingly recognized as a core biological feature of Long COVID and may account for numerous symptoms previously attributed to anxiety, deconditioning, or psychosomatic mechanisms. Quantitative autonomic testing performed in recent cohorts demonstrates objective abnormalities involving sympathetic and parasympathetic regulation, frequently resembling patterns observed in primary autonomic disorders.
The autonomic nervous system serves as the principal regulator of cardiovascular homeostasis, respiratory control, gastrointestinal function, endocrine secretion, thermoregulation, immune modulation, and cerebral perfusion. Consequently, autonomic disruption may explain the remarkable diversity of Long COVID manifestations, including fatigue, orthostatic intolerance, palpitations, exercise intolerance, gastrointestinal dysfunction, cognitive impairment, sleep disturbances, and endocrine abnormalities.
Etiology and Pathogenesis
Persistent Viral Reservoirs
One leading hypothesis proposes persistence of SARS-CoV-2 antigens or replication-competent viral reservoirs within tissues. Viral remnants have been detected months after acute infection within gastrointestinal mucosa, lymphoid tissues, and nervous system structures.
Persistent antigenic stimulation may drive chronic immune activation, cytokine production, endothelial dysfunction, and autonomic instability. Such mechanisms may explain relapsing-remitting symptom patterns frequently reported by patients.
Immune Dysregulation
Numerous studies demonstrate persistent immune abnormalities after SARS-CoV-2 infection, including:
- Elevated inflammatory cytokines
- T-cell exhaustion
- Altered B-cell populations
- Autoantibody production
- Reactivation of latent viruses
Machine-learning immunophenotyping studies have demonstrated persistent inflammatory signatures among Long COVID cohorts, supporting the hypothesis of chronic immune dysregulation.
Autoimmunity
Autoantibodies targeting autonomic receptors represent another compelling mechanism.
Investigators have identified antibodies directed against:
- β-adrenergic receptors
- Muscarinic acetylcholine receptors
- Angiotensin II receptors
- G-protein coupled receptors
These antibodies may disrupt autonomic signaling pathways, producing symptoms analogous to autoimmune autonomic ganglionopathy.
Endothelial Dysfunction
SARS-CoV-2 exhibits marked tropism for vascular endothelium.
Endothelial injury contributes to:
- Microvascular inflammation
- Reduced nitric oxide bioavailability
- Abnormal vasoconstriction
- Tissue hypoperfusion
- Impaired oxygen extraction
These abnormalities may exacerbate orthostatic intolerance and exercise intolerance.
Mitochondrial Dysfunction
Emerging molecular investigations identify mitochondrial injury as a major contributor to fatigue and autonomic dysfunction.
Potential mechanisms include:
- Reduced ATP production
- Oxidative stress
- Impaired calcium regulation
- Altered cellular metabolism
Network analyses have highlighted mitochondrial signaling pathways and VDAC1-associated mechanisms as potential therapeutic targets.
Vagus Nerve Pathobiology
The vagus nerve occupies a central position in contemporary Long COVID research.
As the primary parasympathetic conduit, the vagus nerve influences:
- Heart rate
- Blood pressure
- Respiratory rhythm
- Gastrointestinal motility
- Pancreatic function
- Splenic immune regulation
- Hypothalamic signaling
Damage or dysfunction of vagal pathways could theoretically produce a substantial proportion of Long COVID symptoms.
Neuroanatomic Considerations
The vagus nerve contains approximately 80% afferent fibers and 20% efferent fibers.
Afferent fibers communicate information from:
- Heart
- Lungs
- Gastrointestinal tract
- Liver
- Pancreas
to brainstem autonomic centers.
Efferent fibers regulate:
- Cardiac chronotropy
- Bronchial tone
- Digestive activity
- Anti-inflammatory pathways
Consequently, vagal dysfunction may disrupt both sensory and regulatory mechanisms simultaneously.
Cholinergic Anti-inflammatory Pathway
The vagus nerve participates in immune regulation through the cholinergic anti-inflammatory reflex.
Normal activation suppresses:
- TNF-α
- IL-1β
- IL-6
- HMGB1
through α7 nicotinic acetylcholine receptor signaling.
Impairment of this pathway may permit persistent systemic inflammation and contribute to ongoing symptomatology.
Evidence for Vagal Dysfunction
Recent studies increasingly support vagal involvement.
Investigators have reported:
- Reduced heart rate variability
- Impaired parasympathetic tone
- Abnormal baroreflex responses
- Altered respiratory variability
- Orthostatic intolerance
Novel pilot studies suggest transcutaneous auricular vagus nerve stimulation may improve dysautonomia, cognitive symptoms, and PTSD manifestations in Long COVID patients.
Effects of Dysautonomia on Organ Systems
Cardiovascular System
Cardiovascular manifestations include:
- Sinus tachycardia
- POTS
- Orthostatic hypotension
- Palpitations
- Exercise intolerance
- Reduced stroke volume
Recent autonomic testing studies demonstrate significant autonomic abnormalities among Long COVID patients referred for evaluation of orthostatic symptoms.
Central Nervous System
Neurological manifestations include:
- Brain fog
- Memory impairment
- Executive dysfunction
- Reduced processing speed
- Sleep disorders
Neuroimaging studies demonstrate abnormalities involving the insula, hippocampus, brainstem, and white matter pathways.
Respiratory System
Potential autonomic contributions include:
- Dysfunctional breathing
- Air hunger
- Dyspnea
- Impaired chemoreceptor responses
Brainstem and vagal abnormalities may contribute significantly to these symptoms.
Gastrointestinal System
Common manifestations include:
- Gastroparesis
- Constipation
- Diarrhea
- Nausea
- Abdominal pain
These symptoms likely reflect disruption of enteric-autonomic interactions and brain-gut axis dysfunction.
Endocrine System
Autonomic dysfunction influences:
- Cortisol regulation
- Insulin secretion
- Thyroid function
- Reproductive hormones
- Growth hormone release
Hypothalamic-pituitary-autonomic interactions may therefore contribute to endocrine manifestations observed in Long COVID.
History and Physical Examination
Evaluation should include:
Symptom History
- Onset following infection
- Orthostatic symptoms
- Palpitations
- Syncope
- Cognitive impairment
- Gastrointestinal symptoms
- Sleep disturbances
- Temperature intolerance
Physical Examination
- Supine blood pressure
- Standing blood pressure
- Standing heart rate
- Neurologic assessment
- Cardiovascular examination
- Volume status evaluation
Diagnostic Testing
- Tilt-table testing
- Heart rate variability analysis
- Sudomotor testing
- QSART
- Skin biopsy for small fiber neuropathy
- Autonomic reflex screening
Recent evidence suggests small-fiber pathology may represent a major mechanism of Long COVID dysautonomia.
Treatment Strategies
Current management remains largely symptomatic.
Nonpharmacologic Approaches
- Increased fluid intake
- Salt supplementation
- Compression garments
- Recumbent exercise
- Pacing strategies
- Sleep optimization
Pharmacologic Therapies
Depending upon phenotype:
- Fludrocortisone
- Midodrine
- Pyridostigmine
- Ivabradine
- Beta blockers
- Droxidopa
Evidence remains limited and individualized treatment is essential.
Neuromodulation
Emerging approaches include:
- Auricular vagus nerve stimulation
- Transcutaneous vagal stimulation
- Brain-gut axis modulation
Recent pilot investigations have demonstrated promising improvements in autonomic symptoms and cognition.
Advanced Pathology of Long COVID–Associated Dysautonomia
Neuroinflammatory Mechanisms
Among the most consistently reported biologic abnormalities in Long COVID is persistent neuroinflammation. Neuroinflammatory activation appears capable of disrupting autonomic control centers throughout the neuraxis, particularly within the brainstem, hypothalamus, insular cortex, anterior cingulate cortex, and nucleus tractus solitarius.
Microglial activation has emerged as a leading mechanistic hypothesis. Microglia serve as the resident immune cells of the central nervous system and play essential roles in synaptic maintenance, neuronal repair, and immune surveillance. Following SARS-CoV-2 infection, prolonged microglial activation may lead to excessive production of inflammatory mediators including:
- Interleukin-1β
- Interleukin-6
- Tumor necrosis factor-alpha
- Interferon-gamma
- Reactive oxygen species
Persistent exposure of autonomic regulatory centers to these mediators may impair neural transmission and autonomic reflex integration.
Postmortem investigations have demonstrated evidence of neuroimmune activation within the medulla, pons, and vagal nuclei. Although direct viral invasion appears uncommon, immune-mediated injury remains a plausible explanation for many neurologic manifestations.
Small Fiber Neuropathy and Autonomic Injury
Small fiber neuropathy (SFN) has become one of the most compelling explanations for Long COVID dysautonomia.
Small unmyelinated C fibers and thinly myelinated A-delta fibers are responsible for:
- Autonomic regulation
- Temperature sensation
- Pain transmission
- Sweat gland function
- Vascular tone
Skin biopsy studies increasingly demonstrate reduced intraepidermal nerve fiber density in subsets of Long COVID patients.
Damage to these fibers may produce:
Cardiovascular Effects
- Orthostatic intolerance
- Tachycardia
- Blood pressure instability
- Syncope
Gastrointestinal Effects
- Gastroparesis
- Dysmotility
- Constipation
- Diarrhea
Thermoregulatory Effects
- Heat intolerance
- Cold intolerance
- Abnormal sweating
Sensory Manifestations
- Burning pain
- Paresthesias
- Dysesthesias
Importantly, small fiber neuropathy may occur even when routine neurologic examinations remain normal, emphasizing the importance of specialized testing.
Genomic and Molecular Mechanisms
Host Genetic Susceptibility
Not all individuals infected with SARS-CoV-2 develop Long COVID or dysautonomia, suggesting host genetic susceptibility.
Current investigations have identified potential associations involving:
HLA Variants
Specific human leukocyte antigen (HLA) alleles may predispose to persistent immune activation and autoimmunity.
Cytokine Regulatory Genes
Variants influencing:
- IL-6 expression
- TNF-alpha production
- Interferon signaling
may determine severity of post-infectious inflammation.
Autonomic Receptor Genes
Polymorphisms involving:
- Adrenergic receptors
- Muscarinic receptors
- Renin-angiotensin signaling
may influence susceptibility to autonomic dysfunction.
Mitochondrial Genomics
Emerging research suggests mitochondrial DNA variation may influence:
- Energy production
- Oxidative stress
- Recovery from viral injury
These pathways are increasingly implicated in chronic fatigue and exercise intolerance.
Endothelial and Microvascular Pathology
Endotheliitis
The vascular endothelium represents one of the principal targets of SARS-CoV-2 pathology.
The endothelium regulates:
- Vascular tone
- Coagulation
- Inflammation
- Immune trafficking
- Tissue perfusion
In Long COVID, persistent endothelial dysfunction may continue long after viral clearance.
Observed abnormalities include:
- Reduced nitric oxide production
- Increased oxidative stress
- Enhanced platelet activation
- Impaired vasodilation
- Microvascular rarefaction
These abnormalities may contribute significantly to autonomic instability.
Microclot Hypothesis
Investigators have identified persistent fibrin amyloid microclots in some Long COVID patients.
These structures may:
- Resist fibrinolysis
- Obstruct capillary circulation
- Impair oxygen delivery
- Promote chronic inflammation
Potential consequences include:
- Fatigue
- Brain fog
- Exercise intolerance
- Dysautonomia
Although controversy remains regarding prevalence and clinical significance, the hypothesis continues to generate substantial research interest.
Hypothalamic Dysfunction
The hypothalamus functions as the master regulator of autonomic and endocrine homeostasis.
Potential hypothalamic injury may disrupt:
Temperature Regulation
Manifestations include:
- Fever-like sensations
- Chills
- Heat intolerance
Appetite Regulation
Manifestations include:
- Weight loss
- Weight gain
- Altered satiety
Sleep-Wake Control
Manifestations include:
- Insomnia
- Hypersomnia
- Circadian disruption
Hormonal Regulation
Manifestations include:
- Adrenal abnormalities
- Thyroid dysfunction
- Gonadal disturbances
Endocrine Consequences of Dysautonomia
Hypothalamic-Pituitary-Adrenal Axis
Chronic autonomic activation may alter cortisol dynamics.
Abnormal findings reported include:
- Blunted cortisol awakening response
- Altered circadian cortisol secretion
- Relative adrenal insufficiency
- Hypercortisolemia in selected patients
These abnormalities may contribute to:
- Fatigue
- Cognitive dysfunction
- Mood disturbances
- Sleep disruption
Thyroid Effects
Autonomic dysfunction may influence thyroid physiology through central regulatory mechanisms.
Reported abnormalities include:
- Non-thyroidal illness syndrome
- Subclinical thyroid dysfunction
- Fluctuating thyroid hormone levels
Even subtle disturbances may exacerbate fatigue and autonomic symptoms.
Pancreatic and Metabolic Effects
Vagal dysfunction may alter:
- Insulin secretion
- Glucagon release
- Glucose homeostasis
Consequences may include:
- Reactive hypoglycemia
- Glucose variability
- Metabolic dysregulation
These abnormalities may worsen fatigue and cognitive impairment.
Cardiovascular Dysautonomia
Postural Orthostatic Tachycardia Syndrome
POTS has become one of the most recognized manifestations of Long COVID.
Diagnostic criteria include:
- Heart rate increase ≥30 beats per minute within 10 minutes of standing
- Absence of orthostatic hypotension
- Chronic symptoms exceeding three months
Common symptoms include:
- Palpitations
- Lightheadedness
- Tremulousness
- Cognitive impairment
- Exercise intolerance
Multiple mechanisms may contribute:
- Hypovolemia
- Small fiber neuropathy
- Autoimmunity
- Hyperadrenergic activation
Orthostatic Hypotension
Some patients develop inadequate vasoconstriction upon standing.
Consequences include:
- Cerebral hypoperfusion
- Syncope
- Falls
- Fatigue
Orthostatic hypotension may indicate more extensive autonomic injury than isolated POTS.
Pulmonary-Autonomic Interactions
The autonomic nervous system plays a critical role in respiratory control.
Potential abnormalities include:
Chemoreceptor Dysfunction
Abnormal responses to:
- Carbon dioxide
- Oxygen
- Acid-base disturbances
may contribute to dyspnea.
Vagal Sensory Dysfunction
Altered pulmonary vagal signaling may create sensations of:
- Air hunger
- Chest tightness
- Inability to take a satisfying breath
despite normal pulmonary function testing.
Gastrointestinal Dysautonomia
The gastrointestinal tract receives extensive autonomic innervation through vagal and enteric pathways.
Manifestations include:
Upper Gastrointestinal
- Nausea
- Early satiety
- Gastroparesis
- Reflux
Lower Gastrointestinal
- Constipation
- Diarrhea
- Bloating
- Abdominal pain
Microbiome disruption may further amplify autonomic dysfunction through the gut-brain axis.
Neurocognitive Dysfunction
Brain Fog
Brain fog remains among the most disabling Long COVID symptoms.
Affected domains include:
- Working memory
- Executive function
- Attention
- Processing speed
- Verbal fluency
Potential mechanisms include:
Neuroinflammation
Persistent inflammatory signaling may impair neuronal communication.
Cerebral Hypoperfusion
Orthostatic intolerance may reduce cerebral blood flow.
Microvascular Dysfunction
Capillary abnormalities may impair nutrient delivery.
Mitochondrial Dysfunction
Reduced cellular energy availability may impair neuronal performance.
Clinical Progression
Long COVID dysautonomia often follows one of several trajectories.
Pattern 1: Gradual Recovery
Symptoms improve over months with supportive management.
Pattern 2: Relapsing-Remitting Disease
Patients experience cycles of:
- Improvement
- Relapse
- Partial recovery
often triggered by exertion or illness.
Pattern 3: Persistent Disability
Symptoms remain severe for years.
Pattern 4: Progressive Autonomic Dysfunction
A minority develop increasingly complex manifestations involving multiple autonomic domains.
Emerging Therapeutic Strategies
Immunomodulation
Investigational therapies include:
- Intravenous immunoglobulin
- Monoclonal antibodies
- Immunoadsorption
- Selective cytokine blockade
These approaches remain under active study.
Antiviral Strategies
Persistent viral reservoir hypotheses have prompted trials evaluating:
- Antiviral therapy
- Combination antiviral regimens
- Viral persistence biomarkers
Further evidence is required before routine use.
Neuromodulation
Future directions include:
Transcutaneous Vagal Nerve Stimulation
Potential effects:
- Reduced inflammation
- Improved autonomic balance
- Enhanced cognition
Transcranial Magnetic Stimulation
Potential effects:
- Neuroplasticity enhancement
- Cognitive improvement
- Mood stabilization
Precision Medicine Approaches
Future management will likely incorporate:
- Genomic profiling
- Autoantibody characterization
- Autonomic phenotyping
- Biomarker-guided therapy
allowing individualized treatment strategies rather than symptom-based approaches alone.
Conclusion
Current evidence increasingly supports the concept that Long COVID dysautonomia is not a single disease but rather a heterogeneous syndrome arising from interacting mechanisms involving neuroinflammation, autonomic neuropathy, endothelial dysfunction, microvascular injury, mitochondrial impairment, immune dysregulation, and vagal nerve dysfunction. The vagus nerve appears to occupy a central position linking inflammatory, cardiovascular, gastrointestinal, endocrine, and neurologic manifestations. Continued investigation into autonomic biology, neuroimmune signaling, and targeted therapeutics will likely define the next generation of treatment strategies for this increasingly recognized chronic disorder.
Selected References
- Keller C, et al. Association of Autonomic Dysfunction With Long COVID. JACC. 2026.
- American College of Cardiology. Long COVID and autonomic dysfunction review. 2025.
- Treadwell JR, et al. Treatments for Long COVID Autonomic Dysfunction. Clin Auton Res. 2025.
- Azabou E, et al. Auricular Vagus Nerve Stimulation in Long COVID. Sci Rep. 2026.
- Journal of Translational Medicine. Brain-Gut Axis Treatments in Long COVID. 2026.
- Eastin E, et al. Long-Term Autonomic Dysfunction in Long COVID. Neurology. 2025.
- Novak P, et al. Shared Autonomic Phenotype of Long COVID and ME/CFS. 2026.
- Yang J, et al. Brain Dysfunction in Long COVID Brain Fog. 2025.
- Park J, et al. Network Analysis of Long COVID Pathophysiology. 2025.
- Yousif MG, et al. Post-COVID Immune Dysregulation. 2023.